Loading clinical trials...
Loading clinical trials...
Exploring the Utility of a Novel BRAF Test in Patients With Melanoma
Conditions
Locations
3
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
May 1, 2013
Primary Completion Date
March 29, 2017
Completion Date
September 1, 2022
Last Updated
September 4, 2024
NCT07177937
NCT02621021
NCT03050268
NCT05969860
NCT03340506
NCT04693377
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions